Portfolio

Thermosome

Re-Inventing Tumor Targeting

Thermosome is a clinical-stage drug develop­ment company focused on targeted tumor therapy with immune stimu­lation for improved cancer therapy. At its core is a novel, proprietary tumor targeting approach that allows for increased local drug concen­trations and improved tumor pene­tration to achieve improved clinical treatment efficacy. The lead candidate THE001 is a thermo­sensitive formu­lation of doxorubicin being developed in soft tissue sarcoma.

Algiax Pharmaceuticals Overview iThera Medical